Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adaptimmune Therapeutics

    NASDAQ: ADAP · Real-Time Price · USD
    0.28
    -0.00 (-1.06%)
    At close: Jun 09, 2025, 3:58 PM

    Adaptimmune Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 178.03M 60.28M 27.15M 6.15M
    Cost of Revenue
    		 70K 9.86M 127.73M 111.09M
    Gross Profit
    		 177.96M 50.42M -100.58M -104.94M
    Operating Income
    		 -68.76M -138.04M -163.97M -162.25M
    Interest Income
    		 6.6M 5.96M 1.54M 1.09M
    Pretax Income
    		 -67.24M -112.53M -162.96M -157.3M
    Net Income
    		 -70.81M -113.87M -165.46M -158.09M
    Selling & General & Admin
    		 81.31M 71.81M 63.39M 57.3M
    Research & Development
    		 149.06M 126.51M 127.73M 111.09M
    Other Expenses
    		 16.35M n/a -536K 3.85M
    Operating Expenses
    		 246.72M 188.42M 191.11M 168.4M
    Interest Expense
    		 3.35M n/a n/a n/a
    Selling & Marketing Expenses
    		 506K n/a n/a n/a
    Cost & Expenses
    		 246.79M 198.28M 191.11M 168.4M
    Income Tax Expense
    		 3.58M 1.34M 2.5M 791K
    Shares Outstanding (Basic)
    		 252.3M 201.07M 161.21M 155.81M
    Shares Outstanding (Diluted)
    		 252.3M 201.07M 161.21M 155.81M
    EPS (Basic)
    		 -0.28 -0.57 -1.02 -1.02
    EPS (Diluted)
    		 -0.28 -0.57 -1.02 -1.02
    EBITDA
    		 -52.66M -128.2M -155.59M -155.68M
    EBIT
    		 -63.89M -138.04M -161.67M -162.25M
    Depreciation & Amortization
    		 11.23M 9.84M 6.07M 6.57M

    Add to Watchlist